Assessment of physical functioning and handling of tiotropium/olodaterol Respimat(®) in patients with COPD in a real-world clinical setting

BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) show signs of reduced physical activity from the early stages of the disease, impacting morbidity and mortality. Data suggest treatment with tiotropium, a long-acting muscarinic antagonist, and olodaterol, a long-acting ß(2)-agon...

Descripción completa

Detalles Bibliográficos
Autores principales: Steinmetz, Karl-Otto, Abenhardt, Birgit, Pabst, Stefan, Hänsel, Michaela, Kondla, Anke, Bayer, Valentina, Buhl, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618035/
https://www.ncbi.nlm.nih.gov/pubmed/31308649
http://dx.doi.org/10.2147/COPD.S195852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618035/
https://www.ncbi.nlm.nih.gov/pubmed/31308649
http://dx.doi.org/10.2147/COPD.S195852

Ejemplares similares